Matches in Nanopublications for { ?s ?p "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP646335.RAf-D5MQfqw-6b341FLL4e1L9WY8kJuYZ9xysE_XU80zo130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646335.RAf-D5MQfqw-6b341FLL4e1L9WY8kJuYZ9xysE_XU80zo130_provenance.
- NP646378.RAe05cjf49gJgGEPmTDI1enLZjQK_hwtPk4ikvu6KAaCU130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646378.RAe05cjf49gJgGEPmTDI1enLZjQK_hwtPk4ikvu6KAaCU130_provenance.
- assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1056018.RAeO0GqoF6LfpewqRmuOBVvxfL3HaGLFH-LNErNhLNTbE130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056018.RAeO0GqoF6LfpewqRmuOBVvxfL3HaGLFH-LNErNhLNTbE130_provenance.
- NP1056024.RABy2-3YxjY8vtiskmdFEf8RhlagQi5ubf6zyGsterWAo130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056024.RABy2-3YxjY8vtiskmdFEf8RhlagQi5ubf6zyGsterWAo130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369784.RAmAF2KyVMV_EKW71Bnam4BMP8LWM0QKYx1f8HzcplGdM130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369784.RAmAF2KyVMV_EKW71Bnam4BMP8LWM0QKYx1f8HzcplGdM130_provenance.
- NP379488.RAvn-vrYWoCn-OQVYBbC4UJQt_eAY9-BlAF83S9KLufWU130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379488.RAvn-vrYWoCn-OQVYBbC4UJQt_eAY9-BlAF83S9KLufWU130_provenance.
- NP1056015.RAsYlv53x3fAt7uQMw3aTf9i-HlTfBuwMBDHvCkbjevaE130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056015.RAsYlv53x3fAt7uQMw3aTf9i-HlTfBuwMBDHvCkbjevaE130_provenance.
- NP379795.RA9ui1YgVULmteCgFfdjJNB4vP254_acAj0xUIS_Le_es130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379795.RA9ui1YgVULmteCgFfdjJNB4vP254_acAj0xUIS_Le_es130_provenance.
- NP1056017.RAwPFsllyr9T0zRB5WLtAywiPa3KCuK6sWp9SsSMOkoLk130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056017.RAwPFsllyr9T0zRB5WLtAywiPa3KCuK6sWp9SsSMOkoLk130_provenance.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.
- NP1056025.RAwPYboxUaM-UxFAA7MQAsamfhwpfROTckQuaW5Sf1xuc130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056025.RAwPYboxUaM-UxFAA7MQAsamfhwpfROTckQuaW5Sf1xuc130_provenance.